ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Treasury Stock
ADC Therapeutics SA
Treasury Stock Peer Comparison
Competitive Treasury Stock Analysis
Latest Figures & CAGR of Competitors
Company | Treasury Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Treasury Stock
-$541k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Treasury Stock
-CHf105k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Treasury Stock
-$62k
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Treasury Stock
-CHf54m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Treasury Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Treasury Stock
-CHf17k
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Treasury Stock?
Treasury Stock
-541k
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Treasury Stock amounts to -541k USD.
What is ADC Therapeutics SA's Treasury Stock growth rate?
Treasury Stock CAGR 1Y
23%
Over the last year, the Treasury Stock growth was 23%.